Nebivolol, carvedilol and metoprolol do not influence cardiac Ca2+ sensitivity

Citation
A. Bundkirchen et al., Nebivolol, carvedilol and metoprolol do not influence cardiac Ca2+ sensitivity, EUR J PHARM, 422(1-3), 2001, pp. 175-180
Citations number
21
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
422
Issue
1-3
Year of publication
2001
Pages
175 - 180
Database
ISI
SICI code
0014-2999(20010622)422:1-3<175:NCAMDN>2.0.ZU;2-D
Abstract
It has been argued that some P-adrenoceptor antagonists may directly influe nce myofibrillar cross-bridge interaction in cardiac skinned fiber preparat ions of animal models. The present study investigates the effects of nebivo lol, metoprolol and carvedilol on tension development of Triton X-100 skinn ed fibers obtained from human failing myocardium as well as on force of con traction and intracellular Ca2+ transient in isolated trabeculae. In skinne d fiber preparations, none of the beta -adrenoceptor antagonists (10 muM) i nfluenced Ca2+ sensitivity of tension development or maximal Ca2+ activated tension (DTmax): control: EC50 for Ca2+: 1.28 +/- 0.05 muM. DTmax: 14.09 /- 0.59 mN/mm(2), nebivolol: 1.36 +/- 0.1 muM, 14.14 +/- 0.95 mN/mm(2); car vedilol: 1.32 +/- 0.11 muM, 13.83 +/- 0.90 mN/mm(2) metoprolol: 1.34 +/- 0. 14 muM, 13.72 +/- 0.36 mN/mm(2). Simultaneous measurement of force and Ca2 transient in the presence of the beta -adrenoceptor antagonists (3 muM) sh owed that the decrease in force of contraction was paralleled by a similar decrease in the intracellular Ca2+ transient. In conclusion, none of the in vestigated P-adrenoceptor antagonists influenced Ca2+ sensitivity of myofib rillar tension development in human failing myocardium. (C) 2001 Published by Elsevier Science B.V.